Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H10AsNO6S |
| Molecular Weight | 311.144 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(C=C1NCS(O)=O)[As](O)(O)=O
InChI
InChIKey=MSEAHRGTAGLWGR-UHFFFAOYSA-N
InChI=1S/C7H10AsNO6S/c10-7-2-1-5(8(11,12)13)3-6(7)9-4-16(14)15/h1-3,9-10H,4H2,(H,14,15)(H2,11,12,13)
| Molecular Formula | C7H10AsNO6S |
| Molecular Weight | 311.144 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Phenarsone sulfoxylate (Aldarsone), a pentavalent arsenical, is a condensation product of 3-amino-4 hydroxylphenylarsonic acid with sodium formaldehyde sulfoxylate. It is an antiamoebic agent. Aldarsone has a spirochetal power superior to that of tryparsamide. Aldarsone may be used in conjunction with artificial fever therapy and penicillin therapy to improve the results in symptomatic syphilis of the central nervous system (neurosyphilis).
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Aldarsone therapy in the treatment of general paresis. | 1948-08 |
|
| Aldarsone and bismuth combined in the treatment of neurosyphilis; report of 100 cases. | 1948-07 |
|
| Aldarsone and neurosyphilis. | 1947-09 |
|
| The use of aldarsone in the treatment of neurosyphilis. | 1946-06 |
|
| ALDARSONE IN NEURO-SYPHILIS. | 1946-06 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:22:38 GMT 2025
by
admin
on
Mon Mar 31 19:22:38 GMT 2025
|
| Record UNII |
QEG0T4K3VZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
QEG0T4K3VZ
Created by
admin on Mon Mar 31 19:22:38 GMT 2025 , Edited by admin on Mon Mar 31 19:22:38 GMT 2025
|
PRIMARY | |||
|
124
Created by
admin on Mon Mar 31 19:22:38 GMT 2025 , Edited by admin on Mon Mar 31 19:22:38 GMT 2025
|
PRIMARY | |||
|
497-97-2
Created by
admin on Mon Mar 31 19:22:38 GMT 2025 , Edited by admin on Mon Mar 31 19:22:38 GMT 2025
|
PRIMARY | |||
|
10810
Created by
admin on Mon Mar 31 19:22:38 GMT 2025 , Edited by admin on Mon Mar 31 19:22:38 GMT 2025
|
PRIMARY | |||
|
C184907
Created by
admin on Mon Mar 31 19:22:38 GMT 2025 , Edited by admin on Mon Mar 31 19:22:38 GMT 2025
|
PRIMARY | |||
|
100000082229
Created by
admin on Mon Mar 31 19:22:38 GMT 2025 , Edited by admin on Mon Mar 31 19:22:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |